BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 12:11:22 AM | Browse: 215 | Download: 355
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 65832
Country/Territory China
2021-03-17 03:49
Peer-Review Started
2021-03-17 04:26
To Make the First Decision
Return for Revision
2021-07-28 13:56
2021-08-11 15:26
Second Decision
2021-11-30 03:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-11-30 19:15
Articles in Press
2021-11-30 19:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-12-31 04:20
Publish the Manuscript Online
2022-01-11 00:11
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers
Manuscript Source Invited Manuscript
All Author List Hui-Yan Sun, Song-Tao Du, Ya-Yun Li, Guang-Tong Deng and Fu-Rong Zeng
Author(s) ORCID Number
Hui-Yan Sun http://orcid.org/0000-0002-5697-933X
Song-Tao Du http://orcid.org/0000-0001-5536-3632
Ya-Yun Li http://orcid.org/0000-0002-4799-663X
Guang-Tong Deng http://orcid.org/0000-0002-4424-9727
Fu-Rong Zeng http://orcid.org/0000-0001-6621-8131
Funding Agency and Grant Number
Funding Agency Grant Number
Fellowship of the China Postdoctoral Science Foundation 2020M682594
Fellowship of the China Postdoctoral Science Foundation 2021T140748
Corresponding Author Fu-Rong Zeng, MD, Doctor, Department of Oncology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan Province, China. zengflorachn@hotmail.com
Key Words Gastrointestinal cancer; Bromodomain and extra-terminal proteins; Bromodomain and extra-terminal inhibitors; Acetylated lysines
Core Tip Bromodomain and extra-terminal (BET) inhibitors, as promising targeted agents, emerge as a new therapeutic avenue for gastrointestinal (GI) cancers. Based on preclinical evidence, BET inhibitors, alone or in combination with other therapies, were effective to suppress the progression of GI cancers.
Publish Date 2022-01-11 00:11
Citation Sun HY, Du ST, Li YY, Deng GT, Zeng FR. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 75-89
URL https://www.wjgnet.com/1948-5204/full/v14/i1/75.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i1.75
Full Article (PDF) WJGO-14-75.pdf
Full Article (Word) WJGO-14-75.docx
Manuscript File 65832_Auto_Edited.docx
Answering Reviewers 65832-Answering reviewers.pdf
Audio Core Tip 65832-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 65832-Conflict-of-interest statement.pdf
Copyright License Agreement 65832-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 65832-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 65832-Language certificate.pdf
Peer-review Report 65832-Peer-review(s).pdf
Scientific Misconduct Check 65832-Bing-Fan JR-2.png
Scientific Editor Work List 65832-Scientific editor work list.pdf